title: Alendronate and etidronate do not regulate interleukin 6 and 11 synthesis in normal human osteoblasts in culture.
abstract: Bisphosphonates exert a potent inhibitory effect on bone resorption. Several studies have been performed, with contradictory results, to ascertain whether the effect of bisphosphonates on osteoclasts could be produced, at least in part, by modulation of the synthesis of resorption-promoting factors by osteoblasts. The aim of this study was to evaluate the effect of etidronate (10-4-10-9 M) and alendronate (10-7-10-12 M) on the production of IL-6 and IL-11 using human osteoblast cultures. Cytokines were quantified by ELISA, and mRNA expression was tested. Treatment with alendronate and etidronate had no effect on the synthesis of IL-6 or IL-11, and IL-6 and IL-11 mRNA levels. These results were obtained both in nonstimulated cultures and in cultures stimulated by means of TNF-a, IL-1b, and TNF-a+IL-1b, with or without FCS. In conclusion, a possible indirect osteoclast-mediated effect of alendronate and etidronate on bone resorption would not be exerted through reduction in osteoblastic synthesis of IL-6 and IL-11.
authors.affiliation: Bone and Joint Physiopathology Research Unit, Institut Municipal d'Investigació Mèdica, Universitat Pompeu Fabra, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Engel
authors.forename: S
authors.initials: S
authors.lastname: Serrano
authors.forename: M L
authors.initials: ML
authors.lastname: Mariñoso
authors.forename: J
authors.initials: J
authors.lastname: Lloreta
authors.forename: F
authors.initials: F
authors.lastname: Ulloa
authors.forename: X
authors.initials: X
authors.lastname: Nogués
authors.forename: A
authors.initials: A
authors.lastname: Diez-Pérez
authors.forename: J
authors.initials: J
authors.lastname: Carbonell
mesh_terms: D000368:Aged; D019386:Alendronate / Q000494:pharmacology*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D012968:Etidronic Acid / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D017370:Interleukin-11 / Q000096:biosynthesis* / Q000235:genetics; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000235:genetics; D008297:Male; D010006:Osteoblasts / Q000187:drug effects* / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D004338:Drug Combinations; D007375:Interleukin-1; D017370:Interleukin-11; D015850:Interleukin-6; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D012968:Etidronic Acid; D019386:Alendronate